Format

Send to

Choose Destination
Trends Biotechnol. 1997 Feb;15(2):71-6.

Hepatitis C virus diagnostics: technology, clinical applications and impacts.

Author information

1
Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD 20892, USA. cathyc@cc.nih.gov

Abstract

Infection with hepatitis C virus (HCV) can cause several significant health problems. Sensitive and specific assays for antibodies to HCV are available to identify and confirm individuals infected with HCV. Evaluation of the clinical impact of HCV infection in a patient includes measuring liver biochemistries and possibly liver biopsy. Molecular assays such as HCV genotype identification and qualitative/quantitative HCV RNA analyses may be valuable in considerations of prognosis and therapy. Further refinement of antibody screening and confirmatory assays and standardization of molecular testing are necessary to optimize testing and thus fully characterize the diagnosis of HCV infection.

PMID:
9081301
DOI:
10.1016/S0167-7799(97)84206-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center